Low-Income Californians Can be Reimbursed for Medical Cannabis

October 15, 2006

, BBSNews

IACM via BBSNews 2006-10-16 -- A Californian court decided in September that medical cannabis users with a low income who receive public assistance benefits from the state may qualify for reimbursement for the cost of medical cannabis. The case centred on Sylvia Price, who uses medical cannabis to alleviate severe pain. Ms. Price sought and received reimbursements for the cost of her medical cannabis under Lake County's public assistance program until 2003 when Lake County stopped reimbursing Ms. Price, claiming that federal law prohibited it from doing so.

In September the administrative court finally resolved the issue by making clear that federal cannabis laws do not prevent the state from honouring its medical cannabis law. (Source: Drug Policy Alliance of 5 October 2006.)

The Netherlands: Indoor cannabis cultivation

Research by scientists of Plant Research International in Wageningen, the Netherlands, showed that the median Dutch illicit grow room consists of 259 cannabis plants, has a plant density of 15 plants per square metre, and 510 W of growth lamps per square metre. For the median Dutch grow room, the predicted yield of female flower buds was 33.7 grams per plant or 505 grams per square metre. (Source: Toonen M, et al. J Forensic Sci 2006;51(5):1050-4.)

Science: Migraine

Researchers of the Institute of Neurology in London found out that the activation of CB1 receptors causes inhibition of the nerve cells that control the blood vessels of the trigeminus nerve. Migraine involves activation, or the perception of activation, of the blood vessel system of the trigeminus. They concluded that these data "suggest that CB receptors may have therapeutic potential in migraine, cluster headache or other primary headaches." (Source: Akerman S, et al. J Pharmacol Exp Ther 2006 Oct 3; [electronic publication ahead of print])

Science: Intranasal administration of THC

THC and the synthetic cannabinoid WIN55,212-2 were administered to the nasal mucosa of rats. Systemic bioavailability of THC was about 5-10 per cent. (Source: Valiveti S, et al. Eur J Pharm Biopharm, 2006 Aug 23; [electronic publication ahead of print])

ONE YEAR AGO:

 

  • Science: Cannabinoids may promote the development of new brain cells
  • Science: Mice without CB1 receptors show accelerated cognitive impairment
  • Australia: Survey on cannabis for medical purposes
  • Science/France: Largest study ever conducted on cannabis and driving found only low increased accident risk for cannabis


Be the first to Comment

Please check your e-mail for a link to activate your account.